Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.

Prdm8 Regulates the Morphological Transition at Multipolar Phase during Neocortical Development

Open access
Inoue, Mayuko, Kuroda, Takao, Honda, Aya, Komabayashi-Suzuki, Mariko, Komai, Tae, Shinkai, Yoichi, Mizutani, Ken-ichi · 2014 · PLoS ONE

Abstract

Here, we found that the PR domain protein Prdm8 serves as a key regulator of the length of the multipolar phase by controlling the timing of morphological transition. We used a mouse line with expression of Prdm8-mVenus reporter and found that Prdm8 is predominantly expressed in the middle and upper intermediate zone during both the late and terminal multipolar phases. Prdm8 expression was almost coincident with Unc5D expression, a marker for the late multipolar phase, although the expression of Unc5D was found to be gradually down-regulated to the point at which mVenus expression was gradually up-regulated. This expression pattern suggests the possible involvement of Prdm8 in the control of the late and terminal multipolar phases, which controls the timing for morphological transition. To test this hypothesis, we performed gain- and loss-of-function analysis of neocortical development by using in utero electroporation. We found that the knockdown of Prdm8 results in premature change from multipolar to bipolar morphology, whereas the overexpression of Prdm8 maintained the multipolar morphology. Additionally, the postnatal analysis showed that the Prdm8 knockdown stimulated the number of early born neurons, and differentiated neurons located more deeply in the neocortex, however, majority of those cells could not acquire molecular features consistent with laminar location. Furthermore, we found the candidate genes that were predominantly utilized in both the late and terminal multipolar phases, and these candidate genes included those encoding for guidance molecules. In addition, we also found that the expression level of these guidance molecules was inhibited by the introduction of the Prdm8 expression vector. These results indicate that the Prdm8-mediated regulation of morphological changes that normally occur during the late and terminal multipolar phases plays an important role in neocortical development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0086356

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Prdm8 expression is mainly restricted to the middle- and upper -IZ during neocortical development. Immunostaining reveals that Prdm8 is weakly expressed in the lower-IZ (A, B). Prdm8 is highly expressed in the middle-IZ and upper-IZ, where its expression almost overlaps with Unc5d expression (B′, B″), which is a marker for late-MP phase, at E15.5. Prdm8-positive cells do not overlap with the Tbr2-positive cells (C), and some Prdm8-positive cells in the lower-IZ are positive for NeuroD1 (D). The mVenus expression pattern in transgenic mouse (E) is similar to the immunostaining pattern obtained with anti-Prdm8 antibody at E15.5 (See also Figure S1A–D, D′). The upregulation of Prdm8 (indicated by the asterisk) occurs in the MP cells at the late-MP phase (F, G, G′, G″). For improved visualization of the cell morphology during the MP phase, the Prdm8-mVenus embryo was electroporated at E12.5 with the CAG-mCherry vector, and analyzed 48 h later. Depending on their position within the IZ, the mCherry-positive MP or BP cells (white or yellow arrows; MP cells in the upper-IZ or lower-IZ, respectively. White arrowheads; BP cells in the upper-IZ) exhibit distinct levels of Prdm8 expression (H, H′, H″). Schematic drawing of the sequential expression of NeuroD1, Unc5D, and Prdm8 that coincides with the process of early post-mitotic differentiation in the neocortical development (K). The nuclei are stained with DAPI in A and E. Scale bars: 100 µm.
Figure 1 Prdm8 expression is mainly restricted to the middle- and upper -IZ during neocortical development. Immunostaining reveals that Prdm8 is weakly expressed in the lower-IZ (A, B). Prdm8 is highly expressed in the middle-IZ and upper-IZ, where its expression almost overlaps with Unc5d expression (B′, B″), which is a marker for late-MP phase, at E15.5. Prdm8-positive cells do not overlap with the Tbr2-positive cells (C), and some Prdm8-positive cells in the lower-IZ are positive for NeuroD1 (D). The mVenus expression pattern in transgenic mouse (E) is similar to the immunostaining pattern obtained with anti-Prdm8 antibody at E15.5 (See also Figure S1A–D, D′). The upregulation of Prdm8 (indicated by the asterisk) occurs in the MP cells at the late-MP phase (F, G, G′, G″). For improved visualization of the cell morphology during the MP phase, the Prdm8-mVenus embryo was electroporated at E12.5 with the CAG-mCherry vector, and analyzed 48 h later. Depending on their position within the IZ, the mCherry-positive MP or BP cells (white or yellow arrows; MP cells in the upper-IZ or lower-IZ, respectively. White arrowheads; BP cells in the upper-IZ) exhibit distinct levels of Prdm8 expression (H, H′, H″). Schematic drawing of the sequential expression of NeuroD1, Unc5D, and Prdm8 that coincides with the process of early post-mitotic differentiation in the neocortical development (K). The nuclei are stained with DAPI in A and E. Scale bars: 100 µm.CC BY · PubMed Central
Figure 2 Prdm8 regulates the morphological changes at the MP phase. In utero electroporation of any one of control (pCAG-IRES-EGFP with pCAG-IRES-Puro; A), or Prdm8 gain-of-function (pCAG-IRES-EGFP with pCAG-Prdm8; B), or Prdm8 loss-of-function (pCAG-IRES-EGFP with pPrdm8sh#629; C) vectors were carried out at E14.5 and the brains were analyzed 60 h after the electroporation. Immunostaining was performed for Tbr1 (magenta) and Unc5D (red) to confirm the SP and middle-IZ, respectively (A′, B′, C′), and examination of the magnified images revealed that the majority of Prdm8 gain-of-function cells predominantly displayed MP morphology (B″, arrows), while Prdm8 loss-of-function cells predominantly displayed premature BP morphologies (C″, arrowheads) in any part of the IZ. Control manipulation contained both MP cells in lower- and middle-IZ, and BP cells in the upper-IZ (A′). Cell morphology was quantified to classify into two groups as “MP” shape and “UP/BP/undefined” shape (D). The number of counted cells was about 180 cells. Data represents the mean ± SD (n>3 slices from 3 individuals). *p<0.05, **p<0.01. Neocortical cells were labeled with a Cre-loxP expression plasmid, pCAG-FloxP-EGFP-N1 and pCAG-Cre, in the presence of either control (E), pCAG-Prdm8 (F), or pPrdm8sh (G) by using in utero electroporation to monitor the morphological difference clearly. The nuclei are stained with DAPI in A–C, E–G. Scale bars: 100 µm.
Figure 2 Prdm8 regulates the morphological changes at the MP phase. In utero electroporation of any one of control (pCAG-IRES-EGFP with pCAG-IRES-Puro; A), or Prdm8 gain-of-function (pCAG-IRES-EGFP with pCAG-Prdm8; B), or Prdm8 loss-of-function (pCAG-IRES-EGFP with pPrdm8sh#629; C) vectors were carried out at E14.5 and the brains were analyzed 60 h after the electroporation. Immunostaining was performed for Tbr1 (magenta) and Unc5D (red) to confirm the SP and middle-IZ, respectively (A′, B′, C′), and examination of the magnified images revealed that the majority of Prdm8 gain-of-function cells predominantly displayed MP morphology (B″, arrows), while Prdm8 loss-of-function cells predominantly displayed premature BP morphologies (C″, arrowheads) in any part of the IZ. Control manipulation contained both MP cells in lower- and middle-IZ, and BP cells in the upper-IZ (A′). Cell morphology was quantified to classify into two groups as “MP” shape and “UP/BP/undefined” shape (D). The number of counted cells was about 180 cells. Data represents the mean ± SD (n>3 slices from 3 individuals). *p<0.05, **p<0.01. Neocortical cells were labeled with a Cre-loxP expression plasmid, pCAG-FloxP-EGFP-N1 and pCAG-Cre, in the presence of either control (E), pCAG-Prdm8 (F), or pPrdm8sh (G) by using in utero electroporation to monitor the morphological difference clearly. The nuclei are stained with DAPI in A–C, E–G. Scale bars: 100 µm.CC BY · PubMed Central
Figure 3 Prdm8 upregulation maintains the MP morphologies and Prdm8 downregulation displayed premature BP transition. In utero electroporation of any one of control (pCAG-IRES-EGFP with pCAG-IRES-Puro; A), or Prdm8 gain-of-function (pCAG-IRES-EGFP with pCAG-Prdm8; B), or Prdm8 loss-of-function (pCAG-IRES-EGFP with pPrdm8sh#629; C) vectors were carried out at E14.5 and brains were analyzed 72 h after the electroporation. Immunostaining with Tbr1 (red, A′, B′, C′) or Unc5D (red, A″, B″, C″) shows the organization of the SP and layer VI neurons or IZ, respectively. The majority of Prdm8 gain-of-function cells occur in different parts of the IZ (B, B′, B″) and show delayed migration into the CP, whereas the control cells are found inside the CP (A, A′). On the other hand, Prdm8 loss-of-function cells increased the EGFP-positive cells inside the CP (C, C′). The positions of EGFP-positive cells within the neocortex in control, CAG-Prdm8, and Prdm8sh plus EGFP plasmids in the brain were examined (D). The number of counted cells was about 203 cells. Data represents the mean ± SD (n>4 slices from 3 individuals); *p<0.05, **p<0.01. To further clarify the role of Prdm8, the WT (E) or Prdm8−/− (F) embryos were electroporated at E14.5 with the CAG-EGFP vector, and analyzed 54 h later. The majority of EGFP-positive cells possessed BP morphology (arrowheads) in Prdm8−/− brains (F′), whereas some EGFP-positive cells in the WT brains with MP morphology (arrows) (E′). The nuclei are stained with DAPI in A–C and E,F Scale bars: 100 µm.
Figure 3 Prdm8 upregulation maintains the MP morphologies and Prdm8 downregulation displayed premature BP transition. In utero electroporation of any one of control (pCAG-IRES-EGFP with pCAG-IRES-Puro; A), or Prdm8 gain-of-function (pCAG-IRES-EGFP with pCAG-Prdm8; B), or Prdm8 loss-of-function (pCAG-IRES-EGFP with pPrdm8sh#629; C) vectors were carried out at E14.5 and brains were analyzed 72 h after the electroporation. Immunostaining with Tbr1 (red, A′, B′, C′) or Unc5D (red, A″, B″, C″) shows the organization of the SP and layer VI neurons or IZ, respectively. The majority of Prdm8 gain-of-function cells occur in different parts of the IZ (B, B′, B″) and show delayed migration into the CP, whereas the control cells are found inside the CP (A, A′). On the other hand, Prdm8 loss-of-function cells increased the EGFP-positive cells inside the CP (C, C′). The positions of EGFP-positive cells within the neocortex in control, CAG-Prdm8, and Prdm8sh plus EGFP plasmids in the brain were examined (D). The number of counted cells was about 203 cells. Data represents the mean ± SD (n>4 slices from 3 individuals); *p<0.05, **p<0.01. To further clarify the role of Prdm8, the WT (E) or Prdm8−/− (F) embryos were electroporated at E14.5 with the CAG-EGFP vector, and analyzed 54 h later. The majority of EGFP-positive cells possessed BP morphology (arrowheads) in Prdm8−/− brains (F′), whereas some EGFP-positive cells in the WT brains with MP morphology (arrows) (E′). The nuclei are stained with DAPI in A–C and E,F Scale bars: 100 µm.CC BY · PubMed Central
Figure 4 Prdm8 alters layer formation in the neocortex. In utero electroporation of any one of control (pCAG-IRES-EGFP with pCAG-IRES-Puro; A), or Prdm8 gain-of-function (pCAG-IRES-EGFP with pCAG-Prdm8; B), or Prdm8 loss-of-function (pCAG-IRES-EGFP with pPrdm8sh#629; C) vectors were carried out at E12.5, and the brains were analyzed at P5. The cortex was divided into 10 bins and the percentage of EGFP-positive cells were quantified (D). The distribution of EGFP-positive cells is significantly increased in the upper bins (bins8–10) and reduced in lower bins (bin5) in the case of the pCAG-Prdm8-electroporated brains, and significantly decreased in upper bins (bins4–6), and increased in lower bins (bins1, 2) in the pPrdm8sh-electroporated brains. The number of counted cells was about 137 cells. Data represents the mean ± SD (n = 6 slices from 3 individuals); *p<0.05, **p<0.01. High-power images showing that the molecular features of control, Prdm8 gain-of-function, or loss-of-function cells in the neocortex, stained with Tbr1 (E, F, G), Ctip2 (K, L, M), RORb (K, L, M) and Brn2 (H, I, J). The percentage of each layer marker-positive EGFP-positive cells located in each layer position was quantified (N). The number of counted cells was about 184 cells. Data represents the mean ± SD (n>4 slices from 4 individuals); **p<0.01. Scale bars: 100 µm (A,E).
Figure 4 Prdm8 alters layer formation in the neocortex. In utero electroporation of any one of control (pCAG-IRES-EGFP with pCAG-IRES-Puro; A), or Prdm8 gain-of-function (pCAG-IRES-EGFP with pCAG-Prdm8; B), or Prdm8 loss-of-function (pCAG-IRES-EGFP with pPrdm8sh#629; C) vectors were carried out at E12.5, and the brains were analyzed at P5. The cortex was divided into 10 bins and the percentage of EGFP-positive cells were quantified (D). The distribution of EGFP-positive cells is significantly increased in the upper bins (bins8–10) and reduced in lower bins (bin5) in the case of the pCAG-Prdm8-electroporated brains, and significantly decreased in upper bins (bins4–6), and increased in lower bins (bins1, 2) in the pPrdm8sh-electroporated brains. The number of counted cells was about 137 cells. Data represents the mean ± SD (n = 6 slices from 3 individuals); *p<0.05, **p<0.01. High-power images showing that the molecular features of control, Prdm8 gain-of-function, or loss-of-function cells in the neocortex, stained with Tbr1 (E, F, G), Ctip2 (K, L, M), RORb (K, L, M) and Brn2 (H, I, J). The percentage of each layer marker-positive EGFP-positive cells located in each layer position was quantified (N). The number of counted cells was about 184 cells. Data represents the mean ± SD (n>4 slices from 4 individuals); **p<0.01. Scale bars: 100 µm (A,E).CC BY · PubMed Central
Figure 5 Candidate genes, preferentially expressed in the late-MP and/or terminal-MP phases. Ten candidate genes were selected by the validation of DNA microarray data (A) (n = 2). Quantitative real-time PCR data shows the expression level of some candidate genes was suppressed by the introduction of pCAG-Prdm8 (B) (n = 4) or pCAG-Unc5D (C) (n = 3). Schematic drawing of a working hypothesis of this study (D).
Figure 5 Candidate genes, preferentially expressed in the late-MP and/or terminal-MP phases. Ten candidate genes were selected by the validation of DNA microarray data (A) (n = 2). Quantitative real-time PCR data shows the expression level of some candidate genes was suppressed by the introduction of pCAG-Prdm8 (B) (n = 4) or pCAG-Unc5D (C) (n = 3). Schematic drawing of a working hypothesis of this study (D).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 58 references

Cited by

See all 41

Metadata

Authors
Inoue, M., Kuroda, T., Honda, A., Komabayashi-Suzuki, M., Komai, T., Shinkai, Y., & Mizutani, K.-I.
Affiliations
  • Doshisha University (JP)
  • Kyoto University (JP)
  • RIKEN (JP)
Corresponding author
Mizutani, Ken-ichi
Venue
PLoS ONE
Published
2014-01-29
Volume
9
Issue
1
Pages
e86356
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2079828833
Cited by
41
References
58
Citations by year
2026: 4 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 3 · 2018: 3 · 2017: 5 · 2016: 3 · 2015: 8
FWCI
1.85
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science
  • Precursory Research for Embryonic Science and Technology
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Fetal and Pediatric Neurological Disorders
Keywords
PRDM8, neocortex development, UNC5D, intermediate zone, neuronal migration, cortical lamination
MeSH terms
Histone Methyltransferases, Red Fluorescent Protein, Animals, Bacterial Proteins, Cerebral Cortex, DNA-Binding Proteins, Embryo, Mammalian, Female, Injections, Intraventricular, Luminescent Proteins, Mice, Inbred C57BL, Mice, Inbred ICR, Plasmids, Pregnancy, Histone-Lysine N-Methyltransferase, Uterus, Genes, Reporter, Electroporation, Gene Expression Regulation, Developmental, Mice, Neurogenesis, Gene Knockdown Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prdm8 Regulates the Morphological Transition at Multipolar Phase during Neocortical Development. https://app.cochat.ai/papers/10.1371/journal.pone.0086356
The paper
Inoue, M., Kuroda, T., Honda, A., Komabayashi-Suzuki, M., Komai, T., Shinkai, Y., & Mizutani, K.-I. (2014). Prdm8 Regulates the Morphological Transition at Multipolar Phase during Neocortical Development. PLoS ONE. https://doi.org/10.1371/journal.pone.0086356

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.